Cytopenias

18 registered clinical trials studyying Cytopenias.

Status	Trial	Sponsor	Phase
Unknown	Vitamin B6 on Relieving Linezolid-associated Cytopenias NCT01295801	Chinese PLA General Hospital	—
Completed	The Safety and Effectiveness of r-HuEPO in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Are A NCT00002303	Ortho Pharmaceuticals	N/A
Completed	A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-H NCT00002071	Ortho Pharmaceuticals	N/A
Completed	Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration NCT00000711	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1
Completed	A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage NCT00002263	Sandoz	N/A
Completed	A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stim NCT00002126	Amgen	Phase 2
Completed	A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients Wi NCT00002007	Sandoz	N/A
Completed	A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia NCT00002009	Sandoz	Phase 1
No Longer Available	Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Trans NCT01200017	Christopher Dvorak	—
Completed	Treatment Program for Anemia in AIDS Patients NCT00002022	R W Johnson Pharmaceutical Research Institute	N/A
Completed	A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in NCT00002006	Sandoz	Phase 1
Completed	A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients W NCT00002281	Amgen	N/A
Completed	An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Viru NCT00002008	Sandoz	Phase 1
Completed	The Safety and Effectiveness of r-HuEPO in Patients With AIDS and Anemia Caused by AIDS and Treatment With AZT NCT00002302	Ortho Pharmaceuticals	N/A
Completed	A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of Sub NCT00002073	Ortho Pharmaceuticals	N/A
Completed	A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-H NCT00002072	Ortho Pharmaceuticals	N/A
Completed	A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-H NCT00002042	Ortho Pharmaceuticals	N/A
Completed	A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombina NCT00002258	Sandoz	Phase 1